ArticleExperimental and therapeutic medicine2026
Intravenous leiomyomatosis of the uterus: A case report and literature review.
Article in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intravenous leiomyomatosis (IVL) is a rare benign ovarian tumor that predominantly affects women of reproductive and perimenopausal age, and is often accompanied by uterine fibroids. Patients typically present with symptoms such as menorrhagia, anemia, dysmenorrhea, abdominal pain or a palpable abdominal mass. In its early stages, the clinical manifestations of this disease are highly nonspecific and lack typical features, leading to a high rate of underdiagnosis or misdiagnosis in clinical practice. IVL is classified as a borderline tumor due to its histologically benign characteristics but biologically malignant behaviors, such as vascular invasion and distant spread. When the lesion extends to involve the inferior vena cava or even the heart, recurrent syncope may become the predominant clinical manifestation. With disease progression, sudden cardiac arrest of a fatal type may occur. Surgical resection remains the primary treatment for this condition. Given its high recurrence rate, post-operative follow-up should be conducted in a manner similar to that for malignant tumors, with regular imaging surveillance. To enhance clinical awareness of IVL, the present study describes a case of IVL in a patient whose chief complaint was increased menstrual flow, an atypical presentation. By reviewing the current case, practical insights may be provided into the diagnosis and management of IVL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.